The tumor tissues from bufalin- and vehicle-treated groups were further confirmed by H&E staining (Fig. 5E) and immunohistochemical staining demonstrated expression of CCRK and β-catenin in cancerous lesion tissues (Fig. 5F). The gene discussed is CDK20; the disease is neoplasm.